Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis

Cancer Research

Volumn 61, Issue 3, 2001, Pages 1207-1213

  Hiratsuka, Sachie ^a   Maru, Yoshiro ^a   Okada, Akiko ^a   Seiki, Motoharu ^a   Noda, Tetsuo ^b   Shibuya, Masabumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; GENE CONTROL; GENE OVEREXPRESSION; GENOTYPE; HISTOPATHOLOGY; LUNG CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL DIVISION; ENDOTHELIAL GROWTH FACTORS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; LIGANDS; LYMPHOKINES; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; PREGNANCY PROTEINS; PROTEIN-TYROSINE KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035114105     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Mechanisms of angiogenesis
2. The biology of vascular endothelial growth factor
3. Structure and function of VEGF receptor-1 and -2
4. Endothelial receptor tyrosine kinases involved in angiogenesis
5. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
6. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
7. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
8. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
9. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family
10. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit
11. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
12. Genomic organization of the flt-1 gene encoding for vascular endothelial growth factor (VEGF) receptor-1 suggests an intimate evolutionary relationship between the 7-Ig and the 5-Ig tyrosine kinase receptors
13. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor
14. The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCγ
15. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor
16. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF
17. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-γ pathway and partially induces mitotic signals in NIH3T3 fibroblasts
18. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells
19. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR
20. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues
21. Two molecules related to the VEGF receptor are expressed in early endothelial cells during avian embryonic development
22. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells
23. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium
24. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1)
25. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
26. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
27. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
28. Establishment and characterization of a tumorigenic murine vascular endothelial cell line (F-2)
29. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor
30. Specificity of vascular endothelial cell growth factor receptor ligand binding domains
31. Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase)
32. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1
33. Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors
34. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform
35. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
36. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells
37. Neuropilin-1 is a placenta growth factor-2 receptor
38. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic
39. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
40. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3
41. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
42. Inhibition of gelatinase A (MMP-2) by batimastat and Captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma
43. Pathogenesis of ascites tumor growth: Angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining
44. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas
45. Expression and localization of placenta growth factor and P1GF receptors in human meningiomas
46. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors